ArticlePrzeglad gastroenterologiczny2020
Guidelines for
Article in Przeglad gastroenterologiczny, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Probiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children.The Cochrane database of systematic reviews · 2025Pooled it
- Identification of risk factors forWorld journal of gastroenterology · 2025Article
- Observational
- Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.BMC infectious diseases · 2024Observational
- Predictors of Clostridium difficile infection after stoma reversal following TaTME surgery.Updates in surgery · 2023Article
- Delayed Diagnosis of Clostridium difficile Colitis in a 48-Year-Old Woman with a Homozygous Mutation of the UGT1A1 Gene While on Chemotherapy for Colorectal Carcinoma.The American journal of case reports · 2022Article
- Case report of successful treatment of clostridial colitis in a child using enteral oxygen therapy.Anaesthesiology intensive therapy · 2022Article
- Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?Przeglad gastroenterologiczny · 2022Article
- Faecal microbiota transplantation as a non-standard therapy for the treatment ofPrzeglad gastroenterologiczny · 2022Article
- Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.JAMA network open · 2021Article
- Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer.Pharmaceuticals (Basel, Switzerland) · 2021Article
- The Human Gut MicrobeAntibiotics (Basel, Switzerland) · 2021Article
- Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases.Pharmacological reports : PR · 2021Article
- Review
- Gut Dysbiosis andFrontiers in microbiology · 2021Review
- Epidemiology of Clostridioides difficile in South Africa.PloS one · 2021Article
- Skin and gastrointestinal symptoms in COVID-19.Przeglad gastroenterologiczny · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.